284 related articles for article (PubMed ID: 26210156)
1. Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
Mascalchi M; Falchini M; Maddau C; Salvianti F; Nistri M; Bertelli E; Sali L; Zuccherelli S; Vella A; Matucci M; Voltolini L; Pegna AL; Luconi M; Pinzani P; Pazzagli M
J Cancer Res Clin Oncol; 2016 Jan; 142(1):195-200. PubMed ID: 26210156
[TBL] [Abstract][Full Text] [Related]
2. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.
Mascalchi M; Maddau C; Sali L; Bertelli E; Salvianti F; Zuccherelli S; Matucci M; Borgheresi A; Raspanti C; Lanzetta M; Falchini M; Mazza E; Vella A; Luconi M; Pinzani P; Pazzagli M
J Cancer; 2017; 8(12):2223-2230. PubMed ID: 28819424
[TBL] [Abstract][Full Text] [Related]
5. Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer.
Zhang Z; Xiao Y; Zhao J; Chen M; Xu Y; Zhong W; Xing J; Wang M
Respirology; 2016 Apr; 21(3):519-25. PubMed ID: 26661896
[TBL] [Abstract][Full Text] [Related]
6. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.
Lindsay CR; Blackhall FH; Carmel A; Fernandez-Gutierrez F; Gazzaniga P; Groen HJM; Hiltermann TJN; Krebs MG; Loges S; López-López R; Muinelo-Romay L; Pantel K; Priest L; Riethdorf S; Rossi E; Terstappen L; Wikman H; Soria JC; Farace F; Renehan A; Dive C; Besse B; Michiels S
Eur J Cancer; 2019 Aug; 117():60-68. PubMed ID: 31254940
[TBL] [Abstract][Full Text] [Related]
7. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
[TBL] [Abstract][Full Text] [Related]
8. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
Carlsson A; Nair VS; Luttgen MS; Keu KV; Horng G; Vasanawala M; Kolatkar A; Jamali M; Iagaru AH; Kuschner W; Loo BW; Shrager JB; Bethel K; Hoh CK; Bazhenova L; Nieva J; Kuhn P; Gambhir SS
J Thorac Oncol; 2014 Aug; 9(8):1111-9. PubMed ID: 25157764
[TBL] [Abstract][Full Text] [Related]
10. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
11. Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer.
Chudasama D; Barr J; Beeson J; Beddow E; McGonigle N; Rice A; Nicholson A; Anikin V
Anticancer Res; 2017 Jan; 37(1):169-173. PubMed ID: 28011487
[TBL] [Abstract][Full Text] [Related]
12. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
[TBL] [Abstract][Full Text] [Related]
14. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
15. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
16. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
17. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
[TBL] [Abstract][Full Text] [Related]
18. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
[TBL] [Abstract][Full Text] [Related]
19. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
[TBL] [Abstract][Full Text] [Related]
20. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
Mariscal J; Alonso-Nocelo M; Muinelo-Romay L; Barbazan J; Vieito M; Abalo A; Gomez-Tato A; Maria de Los Angeles CC; Garcia-Caballero T; Rodriguez C; Brozos E; Baron F; Lopez-Lopez R; Abal M
Sci Rep; 2016 Nov; 6():37820. PubMed ID: 27901069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
